Current Drug Metabolism

Editor-in-Chief:

Michael Sinz

Bristol Myers Squibb

Princeton, NJ

USA

 

Back

Become EABM
Become Reviewer

Preface [Hot Topic: Management of HIV-1 Drug Resistance: From Novel Drugs and Targets to Clinical Benefit Assessement (Guest Editor: Giovanni Maga)] promotion: free to download

Volume:5   Issue: 4
Pp: i-i
Giovanni Maga
DOI: 10.2174/1389200043335469

HIV-1 Reverse Transcriptase Inhibitors: Current Issues and Future Perspectives

Volume:5   Issue: 4
Pp: 283-290
G. A. Locatelli, R. Cancio, S. Spadari and G. Maga
DOI: 10.2174/1389200043335504

Novel Inhibitors of HIV-1 Integration

Volume:5   Issue: 4
Pp: 291-304
M. Witvrouw, B. Van Maele, J. Vercammen, A. Hantson, Y. Engelborghs, E. De Clercq, C. Pannecouque and Z. Debyser
DOI: 10.2174/1389200043335487

Structural Determinants and Molecular Mechanisms for the Resistance of HIV-1 RT to Nucleoside Analogues

Volume:5   Issue: 4
Pp: 305-316
J. Deval, J. Courcambeck, B. Selmi, J. Boretto and B. Canard
DOI: 10.2174/1389200043335478

Assays for Determination of HIV Resistance to Antiviral Drugs

Volume:5   Issue: 4
Pp: 317-319
Fausto Baldanti, Stefania Paolucci, Luca Dossena and Giuseppe Gerna
DOI: 10.2174/1389200043335496

Resistance to HIV Protease Inhibitors: Mechanisms and Clinical Consequences

Volume:5   Issue: 4
Pp: 321-328
Carmen de Mendoza and Vincent Soriano
DOI: 10.2174/1389200043335522

Glycosidase Inhibitors as Potential HIV Entry Inhibitors?

Volume:5   Issue: 4
Pp: 329-361
Inmaculada Robina, Antonio J. Moreno-Vargas, Ana T. Carmona and Pierre Vogel
DOI: 10.2174/1389200043335513